Item Infomation
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tom D. Y., Reijnders | - |
| dc.contributor.author | Hessel, Peters-Sengers | - |
| dc.contributor.author | Tom van der, Poll | - |
| dc.date.accessioned | 2023-03-21T04:50:48Z | - |
| dc.date.available | 2023-03-21T04:50:48Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.uri | https://link.springer.com/article/10.1186/s13054-023-04359-z | - |
| dc.identifier.uri | https://dlib.phenikaa-uni.edu.vn/handle/PNK/7019 | - |
| dc.description | CC BY | vi |
| dc.description.abstract | We appreciate the insightful comments by Prof. Honoré and colleagues regarding our target trial emulation on the effect of erythromycin in critically ill patients with sepsis [1, 2]. Prof. Honoré and colleagues suggest that, in theory, removal of erythromycin from the circulation by renal replacement therapy (RRT) could dilute the potential effect of erythromycin, and that it may therefore be necessary to exclude patients undergoing RRT. | vi |
| dc.language.iso | en | vi |
| dc.publisher | Springer | vi |
| dc.subject | renal replacement therapy | vi |
| dc.subject | removal of erythromycin | vi |
| dc.title | No evidence for relevant impact of renal replacement therapy on clinical effect of erythromycin in critically ill patients with sepsis | vi |
| dc.type | Book | vi |
| Appears in Collections | ||
| OER- Y học- Điều dưỡng | ||
Files in This Item:
